armored-cart-design-agent
The Armored CAR-T Design Agent provides AI-assisted design of next-generation armored CAR-T cells engineered to express cytokines, chemokines, or other enhancing factors.
Install / Use
npx skills add FreedomIntelligence/OpenClaw-Medical-Skills --skill armored-cart-design-agentInstalls into whichever agent you are using.
SKILL.md
Installable skill definition
Quality Score
Category
Healthcare & Life SciencesSupported Platforms
Our assessment of armored-cart-design-agent
armored-cart-design-agent scores 85/100 on our quality scale, 36th of 47 Healthcare & Life Sciences skills we index.
Its SKILL.md is 7.7 KB long, well organised into 27 sections with 1 code example: a thorough specification that gives an agent plenty to work with.
With 3,034 GitHub stars, it is one of the more widely adopted skills in the catalogue.
Maintenance, license and trust
- The repository was last updated about 4 months ago. That is recent enough to be usable, but agent tooling moves fast, so check the instructions against your agent's current version.
- Our last check on 2026-11-04 found the source still online.
- No license is declared. By default that means all rights are reserved: you can read it, but reusing or redistributing it is not clearly permitted. Ask the author before building on it commercially.
- Its trust signals score 86/100, with 1 caution from licensing, adoption, age or documentation. These come from repository metadata, not a code audit — read the skill file before letting an agent act on it.
Safety scan
No issues foundOur scan of the whole file found no instruction hijacking, hidden characters, credential access, data exfiltration or destructive commands. An AI review of the same text found nothing harmful.
AI review by kimi-k2.7-code on 2026-09-30. Automated pattern scan on 2026-09-29. It catches known dangerous patterns, not every risk — read a skill before letting an agent act on it.
armored-cart-design-agent compared with similar skills
All 4 of these similar skills score higher than armored-cart-design-agent; compare them before choosing.
| Skill | Score | Stars | Updated | Format |
|---|---|---|---|---|
| armored-cart-design-agent (this skill)by FreedomIntelligence | 85 | 3.0k | 4mo ago | SKILL.md |
| taste-skillby Leonxlnx | 100 | 116.8k | 8d ago | CLAUDE.md |
| Claude-Code-Game-Studiosby Donchitos | 100 | 39.7k | 7d ago | CLAUDE.md |
| x402by browser-use | 100 | 121.0k | 3d ago | SKILL.md |
| algorithmic-artby anthropics | 100 | 177.9k | 55d ago | SKILL.md |
Frequently asked questions
- How do I install armored-cart-design-agent?
- Run
npx skills add FreedomIntelligence/OpenClaw-Medical-Skills --skill armored-cart-design-agent. The install tabs above show the steps for each supported agent. - Which AI agents does armored-cart-design-agent work with?
- It is written for Zed, as a SKILL.md file. Other agents that read the same format can often use it too.
- Is armored-cart-design-agent safe to use?
- Our scan of the whole file found no instruction hijacking, hidden characters, credential access, data exfiltration or destructive commands. An AI review of the same text found nothing harmful. It declares no license and scores 86/100 on trust signals. Skills are instructions an agent will follow, so read the file before installing it and do not approve commands you do not understand.
- Is armored-cart-design-agent still maintained?
- The repository was last updated about 4 months ago. That is recent enough to be usable, but agent tooling moves fast, so check the instructions against your agent's current version.
Skill content
View source on GitHubname: 'armored-cart-design-agent' description: 'AI-powered design of armored CAR-T cells with cytokine/chemokine expression for enhanced solid tumor efficacy, including IL-12, IL-15, IL-18, and IL-7 armoring strategies.' measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes. allowed-tools:
- read_file
- run_shell_command
Armored CAR-T Design Agent
The Armored CAR-T Design Agent provides AI-assisted design of next-generation armored CAR-T cells engineered to express cytokines, chemokines, or other enhancing factors. These armored T cells overcome solid tumor challenges including immunosuppressive TME, poor trafficking, and T cell exhaustion, with recent clinical success in lymphoma (IL-18) and ongoing trials with IL-12, IL-15, and IL-7.
When to Use This Skill
- When designing CAR-T cells for solid tumor applications.
- For selecting optimal armoring payloads (cytokines, chemokines).
- To optimize cytokine expression levels and regulation.
- When engineering safety switches for armored constructs.
- For predicting armored CAR-T efficacy and safety profiles.
Core Capabilities
-
Armoring Payload Selection: Choose optimal cytokines for tumor type.
-
Expression Level Optimization: Balance efficacy vs toxicity.
-
Inducible System Design: Engineer regulated expression systems.
-
Safety Switch Integration: Design kill switches and controls.
-
Construct Optimization: Optimize transgene configuration.
-
Efficacy Prediction: Predict enhanced tumor killing.
Armoring Strategies
| Cytokine | Mechanism | Clinical Status | Tumor Types | |----------|-----------|-----------------|-------------| | IL-12 | Th1 polarization, IFN-gamma | Phase I/II | Solid tumors | | IL-15 | T/NK persistence | Phase I/II | Hematologic, solid | | IL-18 | Inflammasome, IFN-gamma | Phase I (promising) | Lymphoma | | IL-7 | T cell survival | Phase I | Multiple | | IL-21 | T cell proliferation | Preclinical | Multiple | | CCL19/21 | T cell trafficking | Preclinical | Solid tumors |
Construct Architecture Options
| Component | Options | Consideration | |-----------|---------|---------------| | Promoter | EF1a, PGK, CAG, NFAT-inducible | Expression level/timing | | Signal Peptide | Native, IL-2ss, IgK | Secretion efficiency | | Cytokine | Membrane-bound vs secreted | Local vs systemic | | Linker | T2A, P2A, IRES | Co-expression efficiency | | Kill Switch | iCasp9, HSV-TK, CD20 | Safety control | | Position | Before/after CAR | Expression balance |
Workflow
-
Input: Target tumor type, TME characteristics, CAR design.
-
Payload Selection: Rank armoring strategies for tumor context.
-
Expression Design: Optimize promoter, levels, regulation.
-
Safety Engineering: Add appropriate control switches.
-
Construct Assembly: Generate optimized DNA sequence.
-
Efficacy Prediction: Model enhanced killing and persistence.
-
Output: Optimized armored CAR construct with annotations.
Example Usage
User: "Design an armored CAR-T for pancreatic cancer targeting mesothelin with IL-12 armoring for TME remodeling."
Agent Action:
python3 Skills/Immunology_Vaccines/Armored_CART_Design_Agent/design_armored_cart.py \
--car_target mesothelin \
--tumor_type pancreatic \
--armoring_payload IL-12 \
--expression_system NFAT_inducible \
--safety_switch iCasp9 \
--backbone lentiviral \
--optimize_codon human \
--output armored_cart_design/
Output Components
| Output | Description | Format | |--------|-------------|--------| | Construct Sequence | Full transgene DNA | .fasta, .gb | | Construct Map | Annotated visualization | .png, .pdf | | Expression Model | Predicted levels | .json | | Safety Analysis | Risk assessment | .json | | Manufacturing Guide | Production recommendations | .md | | Predicted Efficacy | Tumor killing model | .json |
IL-12 Armoring Details
| Aspect | Design Choice | Rationale | |--------|---------------|-----------| | Configuration | Tethered IL-12 (p70) | Localized, reduced toxicity | | Expression | NFAT-inducible | Activation-dependent | | Dose | Low-level expression | Safety optimization | | Combination | With PD-1 knockout | Enhanced activity |
IL-18 Armoring Details
| Aspect | Design Choice | Rationale | |--------|---------------|-----------| | Configuration | Secreted mature IL-18 | Enhanced IFN-gamma | | Expression | Constitutive or inducible | Context-dependent | | Clinical Results | Lymphoma responses | Validated approach | | Combination | With IL-21 | Synergistic |
IL-15 Armoring Details
| Aspect | Design Choice | Rationale | |--------|---------------|-----------| | Configuration | Membrane-tethered IL-15/IL-15Ra | Cis-presentation | | Expression | Constitutive moderate | Persistence without toxicity | | Benefit | Reduced IL-2 dependence | Manufacturing advantage | | Safety | Lower CRS risk | Clinical benefit |
AI/ML Components
Payload Selection:
- TME profiling to match cytokine needs
- Multi-objective optimization
- Clinical outcome modeling
Expression Optimization:
- Promoter strength prediction
- Codon optimization
- mRNA stability modeling
Safety Prediction:
- CRS/ICANS risk modeling
- Off-tumor activity prediction
- Systemic cytokine levels
Safety Considerations
| Risk | Mitigation | Implementation | |------|------------|----------------| | Cytokine storm | Inducible expression | NFAT promoter | | Systemic toxicity | Membrane tethering | Localized effect | | Uncontrolled proliferation | Kill switch | iCasp9 | | On-target off-tumor | Regulatable CAR | Logic gates |
Clinical Trials (2025-2026)
| Trial | Armoring | Target | Cancer | Status | |-------|----------|--------|--------|--------| | NCT03721068 | IL-18 | CD19 | Lymphoma | Phase I (positive) | | NCT04119024 | IL-12 | GD2 | Neuroblastoma | Phase I | | NCT03932565 | IL-15/21 | CD19 | B-ALL | Phase I | | Multiple | IL-7/CCL19 | Various | Solid | Preclinical |
Prerequisites
- Python 3.10+
- Biopython for sequence handling
- CAR design databases
- Codon optimization tools
- Structure prediction (optional)
Related Skills
- CART_Design_Optimizer_Agent - Base CAR optimization
- NK_Cell_Therapy_Agent - NK cell engineering
- Cytokine_Storm_Analysis_Agent - Safety analysis
- TCell_Exhaustion_Analysis_Agent - Exhaustion prevention
Manufacturing Considerations
| Aspect | Armored CAR Challenge | Solution | |--------|----------------------|----------| | Vector Size | Larger transgene | Optimize construct | | Transduction | Lower efficiency | Increase MOI | | Expansion | Cytokine effects | Tune expression | | Characterization | Complex phenotype | Enhanced QC |
Special Considerations
- Tumor Type Matching: Different tumors need different armoring
- Expression Timing: Constitutive vs inducible tradeoffs
- Dose Finding: Balance efficacy vs toxicity
- Combination: Consider with checkpoint knockout
- Manufacturing: Larger constructs affect production
Efficacy Enhancement Mechanisms
| Mechanism | Cytokine | Effect | |-----------|----------|--------| | Persistence | IL-15, IL-7 | Longer survival | | TME Remodeling | IL-12 | M2→M1, DC activation | | Bystander Killing | IL-18 | Enhanced IFN-gamma | | Trafficking | CCL19/21 | T cell recruitment | | Anti-exhaustion | IL-21 | Stem-like maintenance |
Author
AI Group - Biomedical AI Platform
<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->Related Skills
taste-skill
116.8kAgent skills that give coding agents taste: art direction, reference images and a browser check instead of generic AI pages
Claude-Code-Game-Studios
39.7kTurn Claude Code into a full game dev studio — 49 AI agents, 72 workflow skills, and a complete coordination system mirroring real studio hierarchy.
x402
121.0kSet up Browser Use Cloud payments with x402 — pay per request from a crypto wallet (USDC on Base mainnet), no signup or API key.
algorithmic-art
177.9kCreating algorithmic art using p5.js with seeded randomness and interactive parameter exploration. Use this when users request creating art using code, generative art, algorithmic art, flow fields, or particle systems.
Languages
Trust signals
From repository metadata: license, adoption, age and documentation. Not a code audit — see the Safety scan above for what the skill file itself contains.
